Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Executives Buy More Than $1B Of 4 Stocks

Published 17/03/2022, 12:20
© Reuters.  Executives Buy More Than $1B Of 4 Stocks
OXY
-
OXYP34
-
OXY_t
-
PCOR
-
CTKB
-
CWAN
-

Although US stock futures traded lower this morning on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Procore Technologies

  • The Trade: Procore Technologies, Inc. (NYSE: PCOR) Director William J.G. Griffith acquired a total of 1,173,958 shares at an average price of $50.88. To acquire these shares, it cost around $59.73 million.
  • What’s Happening: Procore Technologies reported its launch in France as part of continued global expansion and growth.
  • What Procore Technologies Does: Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products.
Occidental Petroleum
  • The Trade: Occidental Petroleum Corporation (NYSE: NYSE:OXY) 10% owner Warren E Buffett acquired a total of 18,102,616 shares at an average price of $54.41. To acquire these shares, it cost around $984.96 million.
  • What’s Happening: Morgan Stanley (NYSE:MS), on Monday, downgraded Occidental Petroleum from Overweight to Equal-Weight.
  • What Occidental Petroleum Does: Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East.
Also check this: Alphabet (NASDAQ:GOOGL) And 4 Other Stocks Sold By Insiders

Cytek Biosciences

  • The Trade: Cytek Biosciences, Inc. (NASDAQ: CTKB) Director Rajeev Shah bought a total of 583,870 shares at an average price of $12.31. To acquire these shares, it cost around $7.19 million.
  • What’s Happening: The company, last month, posted upbeat quarterly sales.
  • What Cytek Biosciences Does: Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.
Clearwater Analytics Holdings
  • The Trade: Clearwater Analytics Holdings, Inc. (NYSE: CWAN) 10% owner Durable Capital Partners Lp bought a total of 498,113 shares at an average price of $16.98. The insider spent around $8.46 million to buy those shares.
  • What’s Happening: Clearwater Analytics recently reported Q4 earnings results and issued guidance.
  • What Clearwater Analytics Holdings Does: Clearwater Analytics Holdings Inc provides investment accounting and reporting, performance measurement, compliance monitoring, and risk analytics solutions for asset managers, insurance companies, and large corporations.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.